Westend-Innovation UG
    Industry / private company
    
    
        Location: 
        München,
        
                Germany (DE)
                
    
 
        
    
    
        ISNI: -
    
    
    
    
    
    
        
    
        
    
        
    
    
    
        
            
                
  
  Efficient Elimination of Cells from Patients with Different AML Subtypes by Dual-Targeting Triplebody 33-16-123 (2019)
  Braciak T, Fenn N, Wildenhain S, Schiller C, Roskopf C, Schubert I, Jacob U, et al.
  Conference contribution
            
                
  
  Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells (2018)
  Braciak TA, Roskopf CC, Wildenhain S, Fenn NC, Schiller CB, Schubert IA, Jacob U, et al.
  Journal article